By Thomas Green The ONE Group Hospitality, Inc. (Nasdaq: STKS) today reported a strong fourth quarter and full year 2023 fueled by new restaurants and improved restaurant operating profit.  In the fourth quarter 2023 total GAAP revenues increased 1.8% to...

By Thomas Green Solo Brands, Inc. (NYSE: DTC) gave guidance for 2024, with total revenue is expected to be between $490 million to $510 million, it said. Adjusted EBITDA margin is expected to be between 10% to 12% for 2024,...

By Exec Edge Editorial Staff In the rapidly evolving landscape of technology, few innovations have captured the imagination and potential for transformation quite like lidar. Standing for Light Detection and Ranging, Hesai lidar (NASDAQ: HSAI) has emerged as a game-changer...

By Thomas Green Kohl’s Corp. (NYSE:KSS) said fourth quarter net income was $186 million compared to net loss of $273 the year prior, helped by its Sephora partnership and improved operations.  Kohl’s reported operating income in the fourth quarter was $299...

By Thomas Green On Running (NYSE: ONON) said net sales increased 46.6% in 2023, reaching CHF 1,792.1 million. Increased brand awareness in fourth quarter boosted direct-to-customer sales to 46.2% and helped On achieve a sales growth of over 31% on...

By Karen Roman Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a clinical-stage life science company, reported it has opened a new cutting-edge laboratory space in Cambridge, U.K. This new facility sits within a space of 150 acres and 2 million square feet...

By Karen Roman Gryphon Digital Mining, Inc. (Nasdaq: GRYP), a sustainable bitcoin miner, announced its average self-mining hashing power rose to an all-time high of 911 PH/s in February 2024, increasing 5% monthly with the operation of newer generation S19k...

By Daniella Parra The Duckhorn Portfolio, Inc. (NYSE: NAPA) saw a gross profit of $58.3 million, an increase of $3.1 million, and an adjusted EBITDA of $42.7 million, an increase of $3.9 million for the fiscal second quarter 2024, they...

By Daniella Parra Promontory Therapeutics Inc. completed enrollment of 109 late-stage metastatic castration-resistant prostate cancer patients for its Phase 2 trial of PT-112, which assesses its efficacy in patients who have undergone prior treatments, the company said. PT-112 is a...

By Karen Roman Potbelly Corporation (Nasdaq: PBPB), the neighborhood sandwich shop company originally from Chicago, reported its total revenue grew 4.7% to $125.7 million in the last quarter of 2023, compared to $120.2 million in 2022. Average Weekly Sales (AWS)...